60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$3.3M
Cash & Equivalents
$2.7M
Quarterly Burn Rate
4 mo
Est. Cash Runway
$4M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-07-15 Phase2 Readout
2026-12-08 Phase1 Readout
2027-01-01 Phase1 Readout
2027-03-18 Phase3 Readout
2027-04-01 Phase1 Readout

Active Clinical Trials (28)

NCT #TitlePhaseStatusEnrollment
NCT07395752 Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study OTHER Recruiting 100
NCT06447168 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholang... OTHER Recruiting 424
NCT06955481 Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1 OTHER Recruiting 120
NCT06690372 Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming OTHER Recruiting 16
NCT07342816 Impact of Mindfulness on Athletic Performance and Functional Movement in Collegiate Athletes OTHER Recruiting 126
NCT05921747 The Impact of Innovative Technology Strategies on Implementing Exercise Programs Using Fully Immersive Virtual Reality f... OTHER Active Not Recruiting 34
NCT05964829 Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis OTHER Recruiting 14
NCT06538064 A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Ca... OTHER Recruiting 30
NCT07080814 The Effect of Balance Training Using a Dynamometric Platform in Patients Undergoing Total Knee Arthroplasty OTHER Recruiting 46
NCT05807594 Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0 OTHER Recruiting 144
NCT07214844 A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablatio... OTHER Recruiting 110
NCT06890572 Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients OTHER Recruiting 44
NCT06810180 Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Het... OTHER Recruiting 200
NCT06669741 Clinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear OTHER Enrolling By Invitation 140
NCT06950125 Evaluation of the JUICE HA® as an Anti-sarcopenia OTHER Recruiting 60
NCT07144930 Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments OTHER Recruiting 210
NCT03715517 Spinal Anesthesia For Enhanced Recovery After Liver Surgery OTHER Recruiting 128
NCT06829836 Can You Breathe Your Way To Better Health? OTHER Enrolling By Invitation 36
NCT06906497 Lebrikizumab in Moderate-to-severe Atopic Dermatitis PHASE4 Recruiting 48
NCT07298759 The Effect of Hydroxytyrosol Administration on Superoxide Dismutase, Pulsatility Index and Resistance Index of Uterine A... OTHER Active Not Recruiting 52
NCT06971510 Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury OTHER Active Not Recruiting 32
NCT06793397 A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder PHASE3 Recruiting 330
NCT05966194 RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer PHASE2 Recruiting 216
NCT06254612 A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder PHASE2 Active Not Recruiting 456
NCT05379634 A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies PHASE2 Active Not Recruiting 36
NCT03152318 A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 PHASE1 Active Not Recruiting 62
NCT06450210 Safety for Home Administration of Microdose Psilocybin Use PHASE1 Recruiting 20
NCT06694753 Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall ... PHASE1 Active Not Recruiting 96

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-07-09 8-K 60 DEGREES PHARMACEUTICALS, INC. (SXTP, SXTPW) (CIK 0001946563) - CURRENT REPORT EDGAR
2026-06-03 8-K 60 DEGREES PHARMACEUTICALS, INC. (SXTP, SXTPW) (CIK 0001946563) - CURRENT REPORT EDGAR

More Analysis